Stopping the #Cure: Why #CancerResearch isn’t Focused On the #TrueCause of #Cancer

By Tony Isaacs

In a hurry? Click here to read the Article Summary...

Since the war on cancer was declared half a century ago, hundreds of billions of dollars have been poured into cancer research. However, despite annual pronouncements of cures and breakthroughs that are just around the corner, all that research has failed to keep the incidence of cancer from continuing to increase. Most of the small reductions in cancer deaths are due mostly to earlier detection which increases five year survival rates – the yardstick conventional medicine uses to determine success.

There is a very good explanation for why cancer research has failed so badly…

It has been directed away from the true main cause of most cancer – toxins. In early years, such misdirection could be partially explained by the lack of understanding about the nature and causes of cancer. In recent decades, however, cancer research has been directed away from toxins even as the evidence has mounted that toxins are indeed the primary cause of cancer. The reasons for misdirecting cancer research are two-fold:

1. Covering up the culpability of those who produce toxins and sell toxic products
2. Greed on the part of mainstream medicine and others who profit from cancer

As an example of the way cancer causes are covered up and the greed that drives the cancer industry, consider the marketing of “pink.” Many of the companies who are part of the hugely publicized Breast Cancer Awareness Movement (BCAM) sell pink-themed products which contain cancer causing toxins.

The Great Pink “Cancer Cover-Up”

There has been a huge effort for many decades to direct attention away from toxins. If toxins were recognized as primary causers of cancer, this would focus attention on the industries which produce toxins as well as the companies whose products contain toxins.

Consequently, many of those who cause cancer have joined together to direct research away from toxins and towards such outdated areas as genetic cancer causes. To make sure they keep the spotlight off toxins, cancer-causing companies have endeavored to place representatives in key positions in both government agencies and non-profit organizations. Such agencies and organizations

Millions Wrongly Treated for 'Cancer,' National Cancer Institute Panel Confirms

Sayer Ji, Founder

A devastating new report commissioned by the National Cancer Institute reveals that our 40-year long 'War on Cancer' has been waged against a vastly misunderstood 'enemy,' that in many cases represented no threat to human health whatsoever.

If you have been following our advocacy work on cancer, particularly in connection with the dark side of breast cancer awareness month, you know that we have been calling for the complete reclassification of some types of 'breast cancer' as benign lesions, e.g. ductal carcinoma in situ (DCIS), as well as pointing out repeatedly that x-ray based breast screenings are not only highly carcinogenic but are also causing an epidemic of "overdiagnosis" and "overtreatment" in US women, with an estimated 1.3 million cases in the past 30 years alone.

This week, a National Cancer Institute commissioned panel's report published in JAMA online confirmed that we all – public and professionals alike – should stop calling low-risk lesions like DCIS and high-grade prostatic intraepithelial neoplasia (HGPIN) 'cancer.'

There are wide-reaching implications to this recommendation, including: 

• Millions of women in this country have been diagnosed with DCIS, and millions of men with HGPIN, and subsequently [mis]treated. Are they now to be retroactively reclassified as 'victims' of iatrogenesis, with legal recourse to seek compensation?
• Anyone engaged in a cancer screening will now need to reconsider and weigh both the risks and benefits of such a 'preventive' strategy, considering that the likelihood of being diagnosed with a false positive over 10 years is already over 50% for women undergoing annual breast screening.
• The burgeoning pink ribbon-bedecked 'breast cancer awareness' industry will be forced to reformulate its message, as it is theoretically culpable for the overdiagnosis and overtreatment of millions of US women by propagating an entirely false concept of 'cancer.'

As reported by Medscape:

The practice of oncology in the United States is in need of a host of reforms and initiatives to mitigate the problem of overdiagnosis and overtreatment of cancer, according to a working group sanctioned by the National Cancer Institute.

Perhaps most dramatically, the group says that a number of premalignant conditions, including ductal carcinoma in situ and high-grade prostatic intraepithelial neoplasia, should no longer be called "cancer."

Instead, the conditions should be labeled something more appropriate, such as indolent lesions of epithelial origin (IDLE), the working group suggests. The Viewpoint report was published online July 29 in JAMA.

Fundamentally, overdiagnosis results from the fact that screen-detected 'cancers' are disproportionately slower growing ones, present with few to no symptoms, and would never progress to cause harm if left undiagnosed and untreated.

As you can see by the graph above, it is the fast-growing tumors which will be more difficult to 'detect early,' and will progress rapidly enough to cause symptoms and perhaps even death unless treated aggressively. But even in the case of finding the tumor early enough to contain it through surgery, chemotherapy and/or radiation, it is well-known that the minority subpopulation of cancer stem cells within these tumors will be enriched and therefore made more malignant through conventional treatment. For instance, radiotherapy radiation wavelengths were only recently found by UCLA Jonnsson Comprehensive Cancer Center researchers to transform breast cancer cells into highly malignant cancer stem-cell like cells, with 30 times higher malignancy post-treatment.

Continue reading:

http://www.greenmedinfo.com/blog/millions-wrongly-treated-cancer-national-cancer-institute-panel-confirms?page=2